主题：【整理】新冠中医成就整理 -- 阴霾信仰

结论我先摘出来，让某些选择性失明人士能偷偷懒：8939名患者中29%用了清肺排毒汤，使用清肺排毒汤的死亡率为1.2%，没用清肺排毒汤的死亡率为4.8%，使用COX回归，排除两组患者临床特征，其他治疗等差异性影响后，接受清肺排毒汤治疗的患者的死亡风险只有未接受清肺排毒汤治疗的患者的一半。

Association between use of Qingfei Paidu Tang and mortality in hospitalized patients with COVID-19: A national retrospective registry study

Author links open overlay panelLihuaZhanga†XinZhenga†XuekeBaiaQingWangaBowangChenaHaiboWangbJiapengLuaShuangHuaXiaoyanZhangaHaiboZhangaJiaminLiuaYingShicZhiyeZhoucLanxiaGancXiLiadJingLiade

https://doi.org/10.1016/j.phymed.2021.153531Get rights and content

Under a Creative Commons licenseopen access

Abstract

Background

Qingfei Paidu Tang (QPT), a formula of traditional Chinese medicine, which was suggested to be able to ease symptoms in patients with Coronavirus Disease 2019 (COVID-19), has been recommended by clinical guidelines and widely used to treat COVID-19 in China. However, whether it decreases mortality remains unknown.

Purpose

We aimed to explore the association between QPT use and in-hospital mortality among patients hospitalized for COVID-19.

Study design

A retrospective study based on a real-world database was conducted.

Methods

We identified patients consecutively hospitalized with COVID-19 in 15 hospitals from a national retrospective registry in China, from January through May 2020. Data on patients’ characteristics, treatments, and outcomes were extracted from the electronic medical records. The association of QPT use with COVID-19 related mortality was evaluated using Cox proportional hazards models based on propensity score analysis.

Results

Of the 8939 patients included, 28.7% received QPT. The COVID-19 related mortality was 1.2% (95% confidence interval [CI] 0.8% to 1.7%) among the patients receiving QPT and 4.8% (95% CI 4.3% to 5.3%) among those not receiving QPT. After adjustment for patient characteristics and concomitant treatments, QPT use was associated with a relative reduction of 50% in-hospital COVID-19 related mortality (hazard ratio, 0.50; 95% CI, 0.37 to 0.66 p < 0.001). This association was consistent across subgroups by sex and age. Meanwhile, the incidences of acute liver injury (8.9% [95% CI, 7.8% to 10.1%] vs. 9.9% [95% CI, 9.2% to 10.7%]; odds ratio, 0.96 [95% CI, 0.81% to 1.14%], p = 0.658) and acute kidney injury (1.6% [95% CI, 1.2% to 2.2%] vs. 3.0% [95% CI, 2.6% to 3.5%]; odds ratio, 0.85 [95% CI, 0.62 to 1.17], p = 0.318) were comparable between patients receiving QPT and those not receiving QPT. The major study limitations included that the study was an observational study based on real-world data rather than a randomized control trial, and the quality of data could be affected by the accuracy and completeness of medical records.

Conclusions

QPT was associated with a substantially lower risk of in-hospital mortality, without extra risk of acute liver injury or acute kidney injury among patients hospitalized with COVID-19.

还有人吹啥英国那个证据级别高的地塞米松的RCT论文，看看他们的生存曲线，死亡率20%起。。。

这死亡率好意思来和中医比。。。

特喵的这死亡率在中国都能叫草菅人命了。金银潭医院中医入驻以后中药组的重症/危重症死亡率才3%。。。

这居然还有一堆人舔啥地塞米松是新冠唯一证实有效的药物。。。

只能说中医黑的良心都被狗吃了，给洋人捧脚就居然能这么香，连眼睛都不要了。